People: DexCom Inc (DXCM.OQ)

DXCM.OQ on NASDAQ Stock Exchange Global Select Market

10:07pm IST
Change (% chg)

$-8.17 (-2.44%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Abbey, Donald 

Mr. Donald M. Abbey serves as Executive Vice President - Quality and Regulatory Affairs of the Company. He has served as our Executive Vice President, Quality and Regulatory Affairs since January 2017 and served as our Executive Vice President, Quality from May 2016 to January 2017. From March 2007 to April 2016 , Mr. Abbey served in executive roles for Becton Dickinson (the acquirer of CareFusion in March 2015 which itself was spun off from Cardinal Health in 2009), including as Senior Vice President, Quality and Regulatory for Becton Dickinson from March 2015 to May 2016, as Executive Vice President, Quality, Regulatory and Medical Affairs for CareFusion from May 2011 to March 2015, as Senior Vice President, Quality and Regulatory for CareFusion from October 2009 to May 2011, and as Senior Vice President, Quality and Regulatory for Cardinal Health from March 2007 to October 2009. Prior to 2007 Mr. Abbey held senior quality and regulatory affairs and general management positions with Respironics, Welch Allyn, and Philips Healthcare. Mr. Abbey began his career at Varian Medical and Boston Scientific holding positions of increasing responsibility in research and development and quality. Mr. Abbey received a B.S.E.E. from Washington State University and an M.B.A. from the University of Washington.

Basic Compensation

Total Annual Compensation, USD 744,354
Restricted Stock Award, USD 2,152,360
Long-Term Incentive Plans, USD --
All Other, USD 22,446
Fiscal Year Total, USD 2,919,160

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kevin Sayer


Quentin Blackford


Jake Leach


Donald Abbey


Andrew Balo


Richard Doubleday

As Of  31 Dec 2019